Polar Asset Management Partners’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-64,537
Closed -$606K 604
2025
Q1
$606K Sell
64,537
-120,708
-65% -$1.27M 0.01% 328
2024
Q4
$1.7M Buy
+185,245
New +$1.36M 0.02% 371
2023
Q1
Sell
-580,177
Closed -$7.99M 1054
2022
Q4
$7.99M Buy
580,177
+2,277
+0.4% +$31.7K 0.1% 290
2022
Q3
$11.8M Sell
577,900
-119,300
-17% -$2.62M 0.14% 210
2022
Q2
$13.5M Buy
697,200
+381,400
+121% +$7.81M 0.16% 183
2022
Q1
$6.8M Buy
+315,800
New +$7.17M 0.07% 338

Other funds holding ANGO

Polar Asset Management Partners's ANGO Position: Q2 2025 in Review

Polar Asset Management Partners sold out of AngioDynamics (ANGO) in Q2 2025, closing a stake of 64,537 shares — an estimated $606K sold.

Polar Asset Management Partners first reported a position in ANGO in Q1 2022 and held it in 6 quarters. The position peaked at $13.5M in Q2 2022. 150 funds tracked by Wall St. Rank hold ANGO as of Q2 2025.

  • Polar Asset Management Partners reported no remaining AngioDynamics position as of Q2 2025 after selling out during the quarter.
  • Polar Asset Management Partners sold 64,537 AngioDynamics shares in Q2 2025, an estimated $606K.
  • Polar Asset Management Partners first reported a position in AngioDynamics in Q1 2022 and held it in 6 quarters.
  • Polar Asset Management Partners's AngioDynamics position peaked at $13.5M in Q2 2022.
  • 150 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2025.

Based on Polar Asset Management Partners's 13F filing for Q2 2025, filed 14 Aug 2025.